[Administration of tobramycin aerosols in patients with nosocomial pneumonia: a preliminary study].

The aim of this study was to assess renal and respiratory tolerance of aerosolized tobramycin in intubated and mechanically ventilated patients with nosocomial pneumonia.
This was a multicenter, randomized, double-blind, placebo controlled study. Thirty-eight mechanically ventilated patients with documented nosocomial pneumonia were included. Patients treated with intravenous betalactam and tobramycin were randomly allocated to receive aerosolized tobramycin (6 mg/kg/day, n = 21) or placebo (n = 17). The aerosol was administered via a pneumatic nebulizer once a day for 5 days.
Respiratory tolerance was good in all but two patients. No acute renal failure occurred. By day 10, 7 patients in the tobramycin group (35%) had been extubated versus 3 in the placebo group (18.5%, p = 0.18). By day 28, 6 patients had died (2 in the tobramycin group and 4 in the placebo group, p = 0.23).
Aerosolized tobramycin was well tolerated in ventilated patients with documented nosocomial pneumonia.
AuthorsP Le Conte, G Potel, E Clémenti, A Legras, D Villers, E Bironneau, J Cousson, D Baron
JournalPresse meĢdicale (Paris, France : 1983) (Presse Med) Vol. 29 Issue 2 Pg. 76-8 (Jan 22 2000) ISSN: 0755-4982 [Print] FRANCE
Vernacular TitleAdministration d'aérosols de tobramycine chez des patients ayant une pneumopathie nosocomiale: étude préliminaire.
PMID10682031 (Publication Type: Clinical Trial, Comparative Study, English Abstract, Journal Article, Multicenter Study, Randomized Controlled Trial)
Chemical References
  • Aerosols
  • Anti-Bacterial Agents
  • Placebos
  • Creatinine
  • Tobramycin
  • Adult
  • Aerosols
  • Aged
  • Anti-Bacterial Agents (administration & dosage, adverse effects)
  • Creatinine (blood)
  • Cross Infection (drug therapy)
  • Data Interpretation, Statistical
  • Double-Blind Method
  • Drug Tolerance
  • Female
  • Humans
  • Intubation, Intratracheal
  • Kidney (drug effects)
  • Male
  • Middle Aged
  • Placebos
  • Pneumonia, Bacterial (drug therapy)
  • Respiration (drug effects)
  • Respiration, Artificial
  • Time Factors
  • Tobramycin (administration & dosage, adverse effects)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: